Search Results - "Doerfler, Alexandria M."
-
1
A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing
Published in Molecular therapy. Methods & clinical development (15-03-2019)“…Adeno-associated viral (AAV) vectors packaging the CRISPR-Cas9 system (AAV-CRISPR) can efficiently modify disease-relevant genes in somatic tissues with high…”
Get full text
Journal Article -
2
Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase
Published in Journal of lipid research (01-12-2020)“…HMG-CoA reductase (Hmgcr) is the rate-limiting enzyme in the mevalonate pathway and is inhibited by statins. In addition to cholesterol, Hmgcr activity is also…”
Get full text
Journal Article -
3
LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study
Published in Molecular therapy. Methods & clinical development (08-12-2022)“…Lipoprotein(a) (Lp(a)) represents a unique subclass of circulating lipoprotein particles and consists of an apolipoprotein(a) (apo(a)) molecule covalently…”
Get full text
Journal Article -
4
Targeting the Apoa1 locus for liver-directed gene therapy
Published in Molecular therapy. Methods & clinical development (11-06-2021)“…Clinical application of somatic genome editing requires therapeutics that are generalizable to a broad range of patients. Targeted insertion of promoterless…”
Get full text
Journal Article -
5
AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
Published in Molecular therapy (03-06-2020)“…Adeno-associated viral (AAV) vectors are a leading candidate for the delivery of CRISPR-Cas9 for therapeutic genome editing in vivo. However, AAV-based…”
Get full text
Journal Article -
6
Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research
Published in Arteriosclerosis, thrombosis, and vascular biology (01-09-2018)“…OBJECTIVE—Atherosclerosis studies in Ldlr knockout mice require breeding to homozygosity and congenic status on C57BL6/J background, a process that is both…”
Get full text
Journal Article -
7
High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner
Published in Atherosclerosis (01-11-2023)“…Despite increased clinical interest in lipoprotein(a) (Lp(a)), many questions remain about the molecular mechanisms by which it contributes to atherosclerotic…”
Get full text
Journal Article -
8
Recent advances in genome editing for cardiovascular disease
Published in Current opinion in cardiology (01-05-2020)“…PURPOSE OF REVIEWThis review highlights recent progress in applying genome editing to the study and treatment of cardiovascular disease (CVD). RECENT…”
Get full text
Journal Article -
9
Intestinal Deletion of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Promotes Expansion of the Resident Stem Cell Compartment
Published in Arteriosclerosis, thrombosis, and vascular biology (01-04-2022)“…The intestine occupies the critical interface between cholesterol absorption and excretion. Surprisingly little is known about the role of de novo cholesterol…”
Get full text
Journal Article -
10
Abstract 425: Genetic Inhibition Of Hepatic Dolichol Biosynthesis Results In Hypolipidemia
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2022)“…Dolichol is a nonsterol isoprenoid derived from the mevalonate pathway. Dehydrodolichyl diphosphate synthase subunit (DHDDS) is a branch point enzyme that - in…”
Get full text
Journal Article -
11
Abstract 123: Intestinal Deletion Of 3-hydroxy-3-methylglutaryl-coenzyme A Reductase Promotes Expansion Of The Resident Stem Cell Compartment
Published in Arteriosclerosis, thrombosis, and vascular biology (01-09-2021)“…Abstract only While the intestine is the critical interface between cholesterol absorption and excretion, surprisingly little is known about the role of de…”
Get full text
Journal Article -
12
Abstract 216: Modeling Statin Hepatotoxicity with Acute Liver Specific Deletion of HmgCoA Reductase
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2018)“…Abstract only Hmg-CoA Reductase (Hmgcr) catalyzes the conversion of Hmg-CoA to mevalonate, which is the rate-limiting step in the cholesterol biosynthetic…”
Get full text
Journal Article -
13
-
14
Somatic editing of Ldlr with AAV-CRISPR is an efficient tool for atherosclerosis research
Published in Arteriosclerosis, thrombosis, and vascular biology (01-09-2018)Get full text
Journal Article -
15
Abstract 032: Somatic Editing of Ldlr with AAV-CRISPR for Atherosclerosis Studies
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2018)“…Abstract only Background: Current methods to study genetic contributions to atherosclerosis are time-consuming and expensive. The Ldlr and Apoe knockout (KO)…”
Get full text
Journal Article -
16
Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase
Published in Journal of lipid research (01-12-2020)“…HMG-CoA reductase (Hmgcr) is the rate-limiting enzyme in the mevalonate pathway and is inhibited by statins. In addition to cholesterol, Hmgcr activity is also…”
Get full text
Journal Article -
17
Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase
Published in Journal of lipid research (01-12-2020)“…HMG-CoA reductase (Hmgcr) is the rate-limiting enzyme in the mevalonate pathway and is inhibited by statins. In addition to cholesterol, Hmgcr activity is also…”
Get full text
Journal Article